{
  "id": 17834786,
  "title": "Spondyloarthritis Biologics 'Game-Changing' for Juvenile Disease",
  "url": "https://urgent.news/2026/11/02/spondyloarthritis-biologics-game-changing-for-juvenile-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T17:25:43.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/spotlight/acr-spa/123682"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Researchers continue to lay the groundwork for expanding treatment in juvenile spondyloarthritis (SpA), borrowing from advances in disease-modifying anti-rheumatic drugs (DMARDs) in adults. Earlier this year, the interleukin...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}